A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis
Maria Ban(University of Cambridge), Stephen Sawcer(University of Cambridge), Jeannette Lechner‐Scott(John Hunter Hospital), James Wason(MRC Biostatistics Unit), Frank Dudbridge(University of Cambridge), Mathew Cox(John Hunter Hospital), N. P. Robertson(University Hospital of Wales), Jacob L. McCauley(University of Cambridge), Philip L. De Jager(Broad Institute), David Sexton(Vanderbilt University), Rebecca L. Zuvich, Annette Baker(Boston Children's Hospital), Margaret A. Pericak‐Vance(University of Miami), Franca Rosa Guerini(Don Carlo Gnocchi Foundation), Alastair Compston(University of Cambridge), Lisa F. Barcellos(University of California, San Francisco), Anu Kemppinen(University of Oxford), Jorge R. Oksenberg(University of California, San Francisco), Adrian J. Ivinson, Laura Bergamaschi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Stephen L. Hauser(University of California, San Francisco), David A. Hafler(Yale University), J.L. Haines(Center for Human Genetics), Sandra D’Alfonso(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 31
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
|Science|2005|2.4k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k